Traditional Treatments are pharmaceutical-based treatments such as Buprenorphine/Suboxone and Counseling. Explore our suite of traditional treatments
Blue Door offers office-based opiate treatment (OBOT), the humane treatment of withdrawal symptoms with medications administered in our medical office setting.
MEDICATION-ASSISTED TREATMENT (MAT)
Buprenorphine is an effective short-term prescription medication used to decrease pain and cravings during withdrawal which can reduce the risk of relapse overdose death. Buprenorphine is also known as Suboxone or Subutex.
Naltrexone (Vivitrol) is used after detox from opiates. Naltrexone helps with cravings and blocks the effects of opiates. Patients using naltrexone do not feel the intoxicating effects from taking opiates, removing the use-reward paradigm found with drug use.
PRN’s are medications used on an “as needed” basis to help with withdrawal symptoms and include such medications as Phenergan and Clonidine.
*Methadone can be a part of traditional therapeutics. However, it is not a modality that Blue Door Therapeutics employs.
COGNITIVE BEHAVIORAL THERAPY WITH A MOTIVATIONAL INTERVIEWING APPROACH
Individual sessions with a licensed counselor offer a private and supportive environment to explore underlying issues and develop a plan for lasting change.
In group therapy, Blue Door patients are both supported and challenged by peers. Group therapy offers a process oriented environment which focuses on emotional intelligence. We limit the number of group participants to ensure effective treatment and patient comfort. Group therapy includes our proprietary BlueQ educational series, which is a mix between Emotional Quotient (EQ) training and Cognitive Behavioral Therapy (CBT). We like to call it life hacks for our patients and their loved ones.
Families are an integral part of the Blue Door process. We do not expect family members to watch from the sidelines but rather to be active participants in the process. From the first step, families are encouraged to participate as evidence shows that when families are involved in their loved one’s treatment, patients have reduced incidences of overdose.